Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Peripheral Blood Classical Monocytes and Plasma Interleukin 10 Are Associated to Neoadjuvant Chemotherapy Response in Breast Cancer Patients.
Valdés-Ferrada J, Muñoz-Durango N, Pérez-Sepulveda A, Muñiz S, Coronado-Arrázola I, Acevedo F, Soto JA, Bueno SM, Sánchez C, Kalergis AM. Valdés-Ferrada J, et al. Among authors: muniz s. Front Immunol. 2020 Jul 9;11:1413. doi: 10.3389/fimmu.2020.01413. eCollection 2020. Front Immunol. 2020. PMID: 32733470 Free PMC article.
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data.
Walbaum B, Acevedo F, Medina L, Bravo ML, Merino T, Camus M, Dominguez F, Mondaca S, Galindo H, Nervi B, Ibañez C, Madrid J, Muñiz S, Peña J, Koch É, Garrido M, Pinto MP, Sánchez C. Walbaum B, et al. Among authors: muniz s. Ecancermedicalscience. 2021 Feb 1;15:1178. doi: 10.3332/ecancer.2021.1178. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33777171 Free PMC article.
Better overall survival in patients who achieve pathological complete response after neoadjuvant chemotherapy for breast cancer in a Chilean public hospital.
Acevedo F, Petric M, Walbaum B, Robin J, Legorburu L, Murature G, Guerra C, Navarro M, Canovas MJ, Sanchez C, Vargas L, Manzor M, Peña J, Muñiz S, Veglia P, Cartes R, Martinez R. Acevedo F, et al. Among authors: muniz s. Ecancermedicalscience. 2021 Feb 11;15:1185. doi: 10.3332/ecancer.2021.1185. eCollection 2021. Ecancermedicalscience. 2021. PMID: 33777178 Free PMC article.
Impact of Adjuvant FOLFOX on Quality of Life and Peripheral Neuropathy Incidence in Patients With Gastric Cancer: A Prospective Cohort Study.
Mondaca S, Pinto MP, Briones J, Caire N, Peña J, Koch É, Muñiz S, Herrera ME, Sánchez C, Galindo H, Pizarro G, Acevedo F, Ibañez C, Balmaceda C, Norero E, Duran D, Garrido M, Nervi B. Mondaca S, et al. Among authors: muniz s. Value Health Reg Issues. 2023 May;35:13-18. doi: 10.1016/j.vhri.2022.12.005. Epub 2023 Feb 17. Value Health Reg Issues. 2023. PMID: 36805388 Free article.
Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.
Acevedo F, Walbaum B, Camus M, Manzor M, Muñiz S, Medina L, Petric M, Reyes P, Domínguez F, Puschel K, Merino T, Bravo ML, Pinto MP, Ibáñez C, Hughes K, Sánchez C. Acevedo F, et al. Among authors: muniz s. Breast Cancer Res Treat. 2023 Jun;199(2):363-370. doi: 10.1007/s10549-023-06909-z. Epub 2023 Mar 29. Breast Cancer Res Treat. 2023. PMID: 36988750
Suboptimal use of ovarian function suppression in very young women with early breast cancer: a real-world data study.
Heredia A, Walbaum B, Vidal M, Itriago L, Camus M, Dominguez F, Manzor M, Martínez R, Murature G, Muñiz S, Navarro M, Guerra C, Merino T, Medina L, Ibañez C, Ramirez K, Acevedo F, Sánchez C. Heredia A, et al. Among authors: muniz s. Breast Cancer Res Treat. 2024 Jan;203(1):173-179. doi: 10.1007/s10549-023-07117-5. Epub 2023 Sep 21. Breast Cancer Res Treat. 2024. PMID: 37733187
69 results